rabbit anticd45 (Santa Cruz Biotechnology)
Santa Cruz Biotechnology is a verified supplier 
90
Structured Review
Santa Cruz Biotechnology
rabbit anticd45
Rabbit Anticd45, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anticd45/anti+cd45/pm28212995-49-30-35
Average 90 stars, based on 1 article reviews
Rabbit Anticd45, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anticd45/anti+cd45/pm28212995-49-30-35
Average 90 stars, based on 1 article reviews
rabbit anticd45 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Immunofluorescence:Article Title: Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib. Article Snippet: Objectives: To investigate the effect of pazopanib on different CTCs subpopulations in patients with recurrent SCLC and evaluate their clinical relevance.. Methods: Peripheral blood was obtained before the administration of pazopanib (n = 56 patients), after the first cycle (n = 35 patients) and at disease progression (n = 45 patients).. CTCs were detected by CellSearch and double immunofluorescent staining using antibodies against the cytokeratins (CK), TTF-1, CD56 and VEGFR2. Incubation:Article Title: Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib. Article Snippet: Objectives: To investigate the effect of pazopanib on different CTCs subpopulations in patients with recurrent SCLC and evaluate their clinical relevance.. Methods: Peripheral blood was obtained before the administration of pazopanib (n = 56 patients), after the first cycle (n = 35 patients) and at disease progression (n = 45 patients).. CTCs were detected by CellSearch and double immunofluorescent staining using antibodies against the cytokeratins (CK), TTF-1, CD56 and VEGFR2. Staining:Article Title: Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib. Article Snippet: Objectives: To investigate the effect of pazopanib on different CTCs subpopulations in patients with recurrent SCLC and evaluate their clinical relevance.. Methods: Peripheral blood was obtained before the administration of pazopanib (n = 56 patients), after the first cycle (n = 35 patients) and at disease progression (n = 45 patients).. CTCs were detected by CellSearch and double immunofluorescent staining using antibodies against the cytokeratins (CK), TTF-1, CD56 and VEGFR2. Expressing:Article Title: Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib. Article Snippet: Objectives: To investigate the effect of pazopanib on different CTCs subpopulations in patients with recurrent SCLC and evaluate their clinical relevance.. Methods: Peripheral blood was obtained before the administration of pazopanib (n = 56 patients), after the first cycle (n = 35 patients) and at disease progression (n = 45 patients).. CTCs were detected by CellSearch and double immunofluorescent staining using antibodies against the cytokeratins (CK), TTF-1, CD56 and VEGFR2. |